The global Immortalized Human Cells market  size is set to grow from  US$ 1619 million in 2024 to US$ 2630 million in 2030; it is expected to grow at a CAGR of 8.4% from 2024 to 2030.

Global Immortalized Human Cells Market Growth and Outlook 2025-31

The global Immortalized Human Cells market size is predicted to grow from US$ 1619 million in 2024 to US$ 2630 million in 2030; it is expected to grow at a CAGR of 8.4% from 2024 to 2030. Immortalized human cells refer to specially treated cells that can proliferate indefinitely in the laboratory without entering the aging stage. Normally, normal human cells enter a state of aging after a certain number of divisions and eventually stop dividing. However, by introducing specific genes (such as the telomerase gene) or treating them with certain chemicals, these cells are immortalized and can survive and reproduce for a long time in vitro culture. United States market for Immortalized Human Cells is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. China market for Immortalized Human Cells is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Europe market for Immortalized Human Cells is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Global key Immortalized Human Cells players cover Lonza, Thermo Fisher Scientific, JSR, Valneva, Sartorius, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023. Infinity Market Research newest research report, the Immortalized Human Cells Industry Forecast looks at past sales and reviews total world Immortalized Human Cells sales in 2023, providing a comprehensive analysis by region and market sector of projected Immortalized Human Cells sales for 2024 through 2030. With Immortalized Human Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immortalized Human Cells industry. This Insight Report provides a comprehensive analysis of the global Immortalized Human Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immortalized Human Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Immortalized Human Cells market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immortalized Human Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immortalized Human Cells. This report presents a comprehensive overview, market shares, and growth opportunities of Immortalized Human Cells market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Ready-to-use &nbsp;&nbsp;&nbsp; Customized Segmentation by Application: &nbsp;&nbsp;&nbsp; Medical Research &nbsp;&nbsp;&nbsp; Vaccine Development &nbsp;&nbsp;&nbsp; Gene Therapy &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Lonza &nbsp;&nbsp;&nbsp; Thermo Fisher Scientific &nbsp;&nbsp;&nbsp; JSR &nbsp;&nbsp;&nbsp; Valneva &nbsp;&nbsp;&nbsp; Sartorius &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Charles River Laboratories &nbsp;&nbsp;&nbsp; Creative Bioarray &nbsp;&nbsp;&nbsp; LABTOO &nbsp;&nbsp;&nbsp; Cytion &nbsp;&nbsp;&nbsp; EditCo &nbsp;&nbsp;&nbsp; Howard Hughes Medical Institute &nbsp;&nbsp;&nbsp; AcceGen &nbsp;&nbsp;&nbsp; BioIVT LLC &nbsp;&nbsp;&nbsp; BioCat GmbH &nbsp;&nbsp;&nbsp; Cytosurge Key Questions Addressed in this Report What is the 10-year outlook for the global Immortalized Human Cells market? What factors are driving Immortalized Human Cells market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Immortalized Human Cells market opportunities vary by end market size? How does Immortalized Human Cells break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Immortalized Human Cells Annual Sales 2019-2030 &nbsp;2.1.2 World Current & Future Analysis for Immortalized Human Cells by Geographic Region, 2019, 2023 & 2030 &nbsp;2.1.3 World Current & Future Analysis for Immortalized Human Cells by Country/Region, 2019, 2023 & 2030 &nbsp;2.2 Immortalized Human Cells Segment by Type &nbsp;2.2.1 Ready-to-use &nbsp;2.2.2 Customized &nbsp;2.3 Immortalized Human Cells Sales by Type &nbsp;2.3.1 Global Immortalized Human Cells Sales Market Share by Type (2019-2024) &nbsp;2.3.2 Global Immortalized Human Cells Revenue and Market Share by Type (2019-2024) &nbsp;2.3.3 Global Immortalized Human Cells Sale Price by Type (2019-2024) &nbsp;2.4 Immortalized Human Cells Segment by Application &nbsp;2.4.1 Medical Research &nbsp;2.4.2 Vaccine Development &nbsp;2.4.3 Gene Therapy &nbsp;2.4.4 Other &nbsp;2.5 Immortalized Human Cells Sales by Application &nbsp;2.5.1 Global Immortalized Human Cells Sale Market Share by Application (2019-2024) &nbsp;2.5.2 Global Immortalized Human Cells Revenue and Market Share by Application (2019-2024) &nbsp;2.5.3 Global Immortalized Human Cells Sale Price by Application (2019-2024) 3 Global by Company &nbsp;3.1 Global Immortalized Human Cells Breakdown Data by Company &nbsp;3.1.1 Global Immortalized Human Cells Annual Sales by Company (2019-2024) &nbsp;3.1.2 Global Immortalized Human Cells Sales Market Share by Company (2019-2024) &nbsp;3.2 Global Immortalized Human Cells Annual Revenue by Company (2019-2024) &nbsp;3.2.1 Global Immortalized Human Cells Revenue by Company (2019-2024) &nbsp;3.2.2 Global Immortalized Human Cells Revenue Market Share by Company (2019-2024) &nbsp;3.3 Global Immortalized Human Cells Sale Price by Company &nbsp;3.4 Key Manufacturers Immortalized Human Cells Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Immortalized Human Cells Product Location Distribution &nbsp;3.4.2 Players Immortalized Human Cells Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Immortalized Human Cells by Geographic Region &nbsp;4.1 World Historic Immortalized Human Cells Market Size by Geographic Region (2019-2024) &nbsp;4.1.1 Global Immortalized Human Cells Annual Sales by Geographic Region (2019-2024) &nbsp;4.1.2 Global Immortalized Human Cells Annual Revenue by Geographic Region (2019-2024) &nbsp;4.2 World Historic Immortalized Human Cells Market Size by Country/Region (2019-2024) &nbsp;4.2.1 Global Immortalized Human Cells Annual Sales by Country/Region (2019-2024) &nbsp;4.2.2 Global Immortalized Human Cells Annual Revenue by Country/Region (2019-2024) &nbsp;4.3 Americas Immortalized Human Cells Sales Growth &nbsp;4.4 APAC Immortalized Human Cells Sales Growth &nbsp;4.5 Europe Immortalized Human Cells Sales Growth &nbsp;4.6 Middle East & Africa Immortalized Human Cells Sales Growth 5 Americas &nbsp;5.1 Americas Immortalized Human Cells Sales by Country &nbsp;5.1.1 Americas Immortalized Human Cells Sales by Country (2019-2024) &nbsp;5.1.2 Americas Immortalized Human Cells Revenue by Country (2019-2024) &nbsp;5.2 Americas Immortalized Human Cells Sales by Type (2019-2024) &nbsp;5.3 Americas Immortalized Human Cells Sales by Application (2019-2024) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Immortalized Human Cells Sales by Region &nbsp;6.1.1 APAC Immortalized Human Cells Sales by Region (2019-2024) &nbsp;6.1.2 APAC Immortalized Human Cells Revenue by Region (2019-2024) &nbsp;6.2 APAC Immortalized Human Cells Sales by Type (2019-2024) &nbsp;6.3 APAC Immortalized Human Cells Sales by Application (2019-2024) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Immortalized Human Cells by Country &nbsp;7.1.1 Europe Immortalized Human Cells Sales by Country (2019-2024) &nbsp;7.1.2 Europe Immortalized Human Cells Revenue by Country (2019-2024) &nbsp;7.2 Europe Immortalized Human Cells Sales by Type (2019-2024) &nbsp;7.3 Europe Immortalized Human Cells Sales by Application (2019-2024) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Immortalized Human Cells by Country &nbsp;8.1.1 Middle East & Africa Immortalized Human Cells Sales by Country (2019-2024) &nbsp;8.1.2 Middle East & Africa Immortalized Human Cells Revenue by Country (2019-2024) &nbsp;8.2 Middle East & Africa Immortalized Human Cells Sales by Type (2019-2024) &nbsp;8.3 Middle East & Africa Immortalized Human Cells Sales by Application (2019-2024) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Immortalized Human Cells &nbsp;10.3 Manufacturing Process Analysis of Immortalized Human Cells &nbsp;10.4 Industry Chain Structure of Immortalized Human Cells 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Immortalized Human Cells Distributors &nbsp;11.3 Immortalized Human Cells Customer 12 World Forecast Review for Immortalized Human Cells by Geographic Region &nbsp;12.1 Global Immortalized Human Cells Market Size Forecast by Region &nbsp;12.1.1 Global Immortalized Human Cells Forecast by Region (2025-2030) &nbsp;12.1.2 Global Immortalized Human Cells Annual Revenue Forecast by Region (2025-2030) &nbsp;12.2 Americas Forecast by Country (2025-2030) &nbsp;12.3 APAC Forecast by Region (2025-2030) &nbsp;12.4 Europe Forecast by Country (2025-2030) &nbsp;12.5 Middle East & Africa Forecast by Country (2025-2030) &nbsp;12.6 Global Immortalized Human Cells Forecast by Type (2025-2030) &nbsp;12.7 Global Immortalized Human Cells Forecast by Application (2025-2030) 13 Key Players Analysis &nbsp;13.1 Lonza &nbsp;13.1.1 Lonza Company Information &nbsp;13.1.2 Lonza Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.1.3 Lonza Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.1.4 Lonza Main Business Overview &nbsp;13.1.5 Lonza Latest Developments &nbsp;13.2 Thermo Fisher Scientific &nbsp;13.2.1 Thermo Fisher Scientific Company Information &nbsp;13.2.2 Thermo Fisher Scientific Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.2.3 Thermo Fisher Scientific Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.2.4 Thermo Fisher Scientific Main Business Overview &nbsp;13.2.5 Thermo Fisher Scientific Latest Developments &nbsp;13.3 JSR &nbsp;13.3.1 JSR Company Information &nbsp;13.3.2 JSR Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.3.3 JSR Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.3.4 JSR Main Business Overview &nbsp;13.3.5 JSR Latest Developments &nbsp;13.4 Valneva &nbsp;13.4.1 Valneva Company Information &nbsp;13.4.2 Valneva Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.4.3 Valneva Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.4.4 Valneva Main Business Overview &nbsp;13.4.5 Valneva Latest Developments &nbsp;13.5 Sartorius &nbsp;13.5.1 Sartorius Company Information &nbsp;13.5.2 Sartorius Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.5.3 Sartorius Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.5.4 Sartorius Main Business Overview &nbsp;13.5.5 Sartorius Latest Developments &nbsp;13.6 Merck &nbsp;13.6.1 Merck Company Information &nbsp;13.6.2 Merck Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.6.3 Merck Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.6.4 Merck Main Business Overview &nbsp;13.6.5 Merck Latest Developments &nbsp;13.7 Charles River Laboratories &nbsp;13.7.1 Charles River Laboratories Company Information &nbsp;13.7.2 Charles River Laboratories Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.7.3 Charles River Laboratories Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.7.4 Charles River Laboratories Main Business Overview &nbsp;13.7.5 Charles River Laboratories Latest Developments &nbsp;13.8 Creative Bioarray &nbsp;13.8.1 Creative Bioarray Company Information &nbsp;13.8.2 Creative Bioarray Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.8.3 Creative Bioarray Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.8.4 Creative Bioarray Main Business Overview &nbsp;13.8.5 Creative Bioarray Latest Developments &nbsp;13.9 LABTOO &nbsp;13.9.1 LABTOO Company Information &nbsp;13.9.2 LABTOO Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.9.3 LABTOO Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.9.4 LABTOO Main Business Overview &nbsp;13.9.5 LABTOO Latest Developments &nbsp;13.10 Cytion &nbsp;13.10.1 Cytion Company Information &nbsp;13.10.2 Cytion Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.10.3 Cytion Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.10.4 Cytion Main Business Overview &nbsp;13.10.5 Cytion Latest Developments &nbsp;13.11 EditCo &nbsp;13.11.1 EditCo Company Information &nbsp;13.11.2 EditCo Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.11.3 EditCo Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.11.4 EditCo Main Business Overview &nbsp;13.11.5 EditCo Latest Developments &nbsp;13.12 Howard Hughes Medical Institute &nbsp;13.12.1 Howard Hughes Medical Institute Company Information &nbsp;13.12.2 Howard Hughes Medical Institute Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.12.3 Howard Hughes Medical Institute Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.12.4 Howard Hughes Medical Institute Main Business Overview &nbsp;13.12.5 Howard Hughes Medical Institute Latest Developments &nbsp;13.13 AcceGen &nbsp;13.13.1 AcceGen Company Information &nbsp;13.13.2 AcceGen Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.13.3 AcceGen Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.13.4 AcceGen Main Business Overview &nbsp;13.13.5 AcceGen Latest Developments &nbsp;13.14 BioIVT LLC &nbsp;13.14.1 BioIVT LLC Company Information &nbsp;13.14.2 BioIVT LLC Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.14.3 BioIVT LLC Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.14.4 BioIVT LLC Main Business Overview &nbsp;13.14.5 BioIVT LLC Latest Developments &nbsp;13.15 BioCat GmbH &nbsp;13.15.1 BioCat GmbH Company Information &nbsp;13.15.2 BioCat GmbH Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.15.3 BioCat GmbH Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.15.4 BioCat GmbH Main Business Overview &nbsp;13.15.5 BioCat GmbH Latest Developments &nbsp;13.16 Cytosurge &nbsp;13.16.1 Cytosurge Company Information &nbsp;13.16.2 Cytosurge Immortalized Human Cells Product Portfolios and Specifications &nbsp;13.16.3 Cytosurge Immortalized Human Cells Sales, Revenue, Price and Gross Margin (2019-2024) &nbsp;13.16.4 Cytosurge Main Business Overview &nbsp;13.16.5 Cytosurge Latest Developments 14 Research Findings and Conclusion

Report	Global Immortalized Human Cells Market Growth 2024-2030
Selected License	Single ID:LPI15994

Buyer Information

Order Summary